-
Wells Fargo Starts Claritev (CTEV) at Equal Weight
-
Claritev's Dale White to end strategic advisor role Dec. 31
-
Claritev stockholders price 1.5M shares at $51.50 each in offering
-
Claritev (CTEV) PT Raised at Piper Sandler; 'Beat and Raise Confirms Turnaround'
-
Claritev (CTEV) PT Raised to $80 at Citi
-
Claritev invests in Klaim to expand healthcare payment solutions
-
Citi Upgrades Claritev (CTEV) to Buy
-
Claritev Corporation renews contracts with ten largest clients
-
Claritev partners with iO Health for AI revenue cycle management in MENA
-
Claritev (CTEV) PT Raised to $86 at Piper Sandler
-
Piper Sandler Upgrades Claritev (CTEV) to Overweight
-
Claritev (CTEV) and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritev’s Expansion into the Middle East
-
Claritev Corporation (CTEV) Halted, News Pending
-
Claritev Corporation (CTEV) and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings
-
Claritev Corporation (CTEV) Appoints Jason Kap to its Board
-
Claritev (CTEV) PT Raised to $19 at Piper Sandler; 'The Fundamental Outlook is Bleak'

